Allied Market Research
Loading...
0
New
New

Single Cell Multi-Omics Market by Type, (Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, and Single Cell Metabolomics), Application (Oncology, Cell Biology, Neurology, and Others), Technique (Single-Cell Isolation & Dispensing and Single-Cell Analysis), and End User, (Academic Institutes, Contract Research Organizations, and Pharmaceutical & Biotech Companies): Global Opportunity Analysis and Industry Forecast, 2021–2030

A11783
Pages: 287
Jun 2021 | 218 Views
   
Author(s) : Smita Nerkar , Onkar Sumant
Tables: 157
Charts: 52
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Single Cell Multi-omics Market

Request Now !

Single Cell Multiomics Market Overview:

The global single cell multiomics market size was valued at $2,458.80 million in 2020 and is projected to reach $13,908.30 million by 2030, registering a CAGR of 19.0% from 2021 to 2030.

Single cell multiomics technology refers to numerous types of molecules from individual cells, which are studied to understand biological insights than deducing from analyzing each molecular layer from separate cells. Single cell multiomics can analyze genome, epigenome, transcriptome, proteome, and metabolome lineages, unlike live-cell fluorescence imaging, which is a method of destroying cells for analysis. Single cell multiomics measures multiple types of the molecule from single cell of the same individual.

Single-Cell-Multiomics-Market--2020-2030

Get more information on this report : Request Sample Pages

Increase in prevalence of technological advancements in single-cell analysis products and rise in number of large-scale genomics studies leveraging single-cell RNA Sequencing (sc-RNA) drive the growth of the single cell multiomics market. Moreover, increasing adoption of personalized medicine for screening and diagnostics of genetic disorders and rising disposable income in emerging economies drive the growth of the single cell multiomics market. However, high cost of single-cell analysis, lack of skilled professionals, and integration of data & limited availability of large online data storage and analysis platforms are expected to restrain the growth of the market. Moreover, increasing funding in research of single cell multiomics is anticipated to provide lucrative growth opportunities for market players.

The outbreak of COVID-19 has disrupted workflows in the healthcare sector across the world. The disease has forced a number of industries to shut their doors temporarily, including several sub-domains of healthcare. Moreover, there has also been a positive effect on various healthcare services, including single cell multiomics. Healthcare experts have found the single cell multiomics market is one of the most rapidly evolving markets. Furthermore, rising chronic diseases, such as cancer and infectious diseases caused due to virus, have boosted the growth of the global single cell multiomics market. Research of single cell multiomics for COVID-19 may create an opportunity for the growth of the target market. For instance, a single-cell multiomics analysis of the human immune response to SARS-CoV-2 infection is reported in Nature Medicine, providing new insights into COVID-19 pathogenesis. In addition, Cambridge Institute of Therapeutic Immunology and Infectious Disease in collaboration with National Institute of Health Research COVID-19 BioResource performed a combined single cell transcriptome, cell-surface protein, and lymphocyte antigen receptor repertoire analysis of peripheral blood from 130 COVID-19 patients with varying disease severity. Moreover, they uncovered evidence of a coordinated immune response that contributes to COVID-19 progression and different cellular components involved that could potentially be targeted for therapeutic intervention.

Single Cell Multi-Omics Market
By Product

Your browser does not support the canvas element.

Single Cell Genomics segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Single Cell Multiomics Market Segmentation  

The global single cell multiomics market is segmented on the basis of type, application, technique, end user, and region. On the basis of type, the market is categorized into single cell genomics, single cell proteomics, single cell transcriptomics, and single cell metabolomics. By application, it is classified into oncology, cell biology, neurology, and others. By technique, it is divided into single-cell isolation & dispensing and single-cell analysis. Furthermore, single-cell isolation is further classified into oncology, cell biology, neurology, and others. Moreover, single-cell analysis is further divided into oncology, cell biology, neurology, and others. By end user, it is segmented into academic institutes, contract research organizations, and pharmaceutical & biotech companies. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Segment Review

Based on application, the market is divided into oncology, cell biology, neurology, and others. Oncology is anticipated to become the fastest-growing segment during the forecast duration. In tumor environment, irrespective of tumor cells or immune cells, there are a large number of specific mutation sites or surface markers. Extensive heterogeneity of cells in the body, timeliness of the expression of related factors, and the dynamic process of changes all seriously affect the effectiveness of the treatment plan. Therefore, oncology has fueled the growth of the single cell multiomics market.

Single Cell Multi-Omics Market
By Application

Your browser does not support the canvas element.

Oncology Segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Snapshot of North America single cell multiomics market  

North America is projected to account for a major share of the global single cell multiomics market during the forecast period. The market in the region is anticipated to grow in future, owing to availability of developed healthcare infrastructure and continuous research activities for the development of advanced technologies in the region. North America is expected to be followed by Europe during the forecast period.

The key market players profiled in the report include Bio-Rad Laboratories (Celsee, Inc.), BGI Genomics Co. Ltd., Cytiva Life Science (Previously GE), Fluidigm Corporation, Illumina, Inc., 10x Genomics, NanoString Technologies, MissionBio, QIAGEN N.V., and Takara Bio.

Single Cell Multi-Omics Market
By Region

2030
North America 
Europe
Asia-pacific
Lamea

Asia Pacific region would exhibit the highest CAGR of 20.4% during 2020-2030.

Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the global single cell multiomics market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict the single cell multiomics market growth is provided in the report.
  • Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing single cell multiomics market opportunities.
  • Extensive analysis of the key segments of the industry helps to understand the application and products of single cell multiomics used across the globe.
  • Key market players and their strategies have been analyzed to understand the competitive outlook of the single cell multiomics market.

Key Market Segments

By Type

  • Single Cell Genomics
  • Single Cell Proteomics
  • Single Cell Transcriptomics
  • Single Cell Metabolomics

By Application

  • Oncology
  • Cell Biology
  • Neurology
  • Others

By Technique

  • Single-Cell Isolation & Dispensing
    • Oncology
    • Cell Biology
    • Neurology
    • Others
  • Single-Cell Analysis
    • Oncology
    • Cell Biology
    • Neurology
    • Others

By End User

  • Academic Institutes
  • Contract Research Organizations
  • Pharmaceutical & Biotech Companies

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China 
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • Rest of LAMEA
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key Benefits for Stakeholders
1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter’s five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Technological advancements in single-cell analysis products
3.5.1.2.Increase in adoption of personalized medicine for the screening and diagnostics of genetic disorders

3.5.2.Restraints

3.5.2.1.High cost of single-cell analysis products
3.5.2.2.Dearth of skilled professionals

3.5.3.Opportunities

3.5.3.1.Increasing funding in the research of single cell multiomics

3.5.4.Impact analysis

3.6.Covid-19 Impact analysis on the single cell multiomics market

CHAPTER 4:SINGLE CELL MULTIOMICS MARKET, BY TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Single Cell Genomics

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country

4.3.Single Cell Proteomics

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country

4.4.Single Cell Transcriptomics

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country

4.5.Single Cell Metabolomics

4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast
4.5.3.Market analysis, by country

CHAPTER 5:SINGLE CELL MULTIOMICS MARKET, BY APPLICATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Oncology

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country

5.3.Cell Biology

5.3.1.Market size and forecast
5.3.2.Market analysis, by country

5.4.Neurology

5.4.1.Market size and forecast
5.4.2.Market analysis, by country

5.5.Others

5.5.1.Market size and forecast
5.5.2.Market analysis, by country

CHAPTER 6:SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE

6.1.Overview

6.1.1.Market size and forecast

6.2.Single-Cell Isolation and Dispensing

6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.2.3.Market size and forecast, by application

6.2.3.1.Oncology

6.2.3.1.1.Market size and forecast

6.2.3.2.Cell Biology

6.2.3.2.1.Market size and forecast

6.2.3.3.Neurology

6.2.3.3.1.Market size and forecast

6.2.3.4.Others

6.2.3.4.1.Market size and forecast

6.3.Single-Cell Analysis

6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
6.3.3.Market size and forecast, by application

6.3.3.1.Oncology

6.3.3.1.1.Market size and forecast

6.3.3.2.Cell Biology

6.3.3.2.1.Market size and forecast

6.3.3.3.Neurology

6.3.3.3.1.Market size and forecast

6.3.3.4.Others

6.3.3.4.1.Market size and forecast

CHAPTER 7:SINGLE CELL MULTIOMICS MARKET, BY END USER

7.1.Overview

7.1.1.Market size and forecast

7.2.Academic Institutes

7.2.1.Market size and forecast, by region
7.2.2.Market analysis, by country

7.3.Contract Research Organizations

7.3.1.Market size and forecast, by region
7.3.2.Market analysis, by country

7.4.Pharmaceutical and Biotech Companies

7.4.1.Market size and forecast, by region
7.4.2.Market analysis, by country

CHAPTER 8:SINGLE CELL MULTIOMICS MARKET, BY REGION

8.1.Overview

8.1.1.Market size and forecast

8.2.North America

8.2.1.Key market trends, growth factors, and opportunities
8.2.2.Market size and forecast, by country

8.2.2.1.U.S. Single cell multiomics market, by type
8.2.2.2.U.S. Single cell multiomics market, by application
8.2.2.3.U.S. Single cell multiomics market, by technique
8.2.2.4.U.S. Single cell multiomics market, by end user
8.2.2.5.Canada Single cell multiomics market, by type
8.2.2.6.Canada Single cell multiomics market, by application
8.2.2.7.Canada Single cell multiomics market, by application
8.2.2.8.Canada Single cell multiomics market, by end user
8.2.2.9.Mexico Single cell multiomics market, by type
8.2.2.10.Mexico Single cell multiomics market, by application
8.2.2.11.Mexico Single cell multiomics market, by application
8.2.2.12.Mexico Single cell multiomics market, by end user

8.2.3.North America market size and forecast, by type
8.2.4.North America market size and forecast, by application
8.2.5.North America market size and forecast, by technique

8.2.5.1.North America single-cell isolation and dispensing, by application
8.2.5.2.North America single-cell analysis, by application

8.2.6.North America market size and forecast, by end user

8.3.Europe

8.3.1.Key market trends, growth factors, and opportunities
8.3.2.Market size and forecast, by country

8.3.2.1.Germany Single cell multiomics market, by type
8.3.2.2.Germany Single cell multiomics market, by application
8.3.2.3.Germany Single cell multiomics market, by application
8.3.2.4.Germany Single cell multiomics market, by end user
8.3.2.5.France Single cell multiomics market, by type
8.3.2.6.France Single cell multiomics market, by application
8.3.2.7.France Single cell multiomics market, by technique
8.3.2.8.France Single cell multiomics market, by end user
8.3.2.9.UK Single cell multiomics market, by type
8.3.2.10.UK Single cell multiomics market, by application
8.3.2.11.UK Single cell multiomics market, by technique
8.3.2.12.UK Single cell multiomics market, by end user
8.3.2.13.Italy Single cell multiomics market, by type
8.3.2.14.Italy Single cell multiomics market, by application
8.3.2.15.Italy Single cell multiomics market, by technique
8.3.2.16.Italy Single cell multiomics market, by end user
8.3.2.17.Spain Single cell multiomics market, by type
8.3.2.18.Spain Single cell multiomics market, by application
8.3.2.19.Spain Single cell multiomics market, by technique
8.3.2.20.Spain Single cell multiomics market, by end user
8.3.2.21.Rest of Europe Single cell multiomics market, by type
8.3.2.22.Rest of Europe Single cell multiomics market, by application
8.3.2.23.Rest of Europe Single cell multiomics market, by technique
8.3.2.24.Rest of Europe Single cell multiomics market, by end user

8.3.3.Europe market size and forecast, by type
8.3.4.Europe market size and forecast, by application
8.3.5.Europe market size and forecast, by technique

8.3.5.1.Europe single-cell isolation and dispensing, by application
8.3.5.2.Europe single-cell analysis, by application

8.3.6.Europe market size and forecast, by end user

8.4.Asia-Pacific

8.4.1.Key market trends, growth factors, and opportunities
8.4.2.Market size and forecast, by country

8.4.2.1.Japan Single cell multiomics market, by type
8.4.2.2.Japan Single cell multiomics market, by application
8.4.2.3.Japan Single cell multiomics market, by technique
8.4.2.4.Japan Single cell multiomics market, by end user
8.4.2.5.China Single cell multiomics market, by type
8.4.2.6.China Single cell multiomics market, by application
8.4.2.7.China Single cell multiomics market, by technique
8.4.2.8.China Single cell multiomics market, by end user
8.4.2.9.Australia Single cell multiomics market, by type
8.4.2.10.Australia Single cell multiomics market, by application
8.4.2.11.Australia Single cell multiomics market, by technique
8.4.2.12.Australia Single cell multiomics market, by end user
8.4.2.13.India Single cell multiomics market, by type
8.4.2.14.India Single cell multiomics market, by application
8.4.2.15.India Single cell multiomics market, by technique
8.4.2.16.India Single cell multiomics market, by end user
8.4.2.17.South Korea Single cell multiomics market, by type
8.4.2.18.South Korea Single cell multiomics market, by application
8.4.2.19.South Korea Single cell multiomics market, by technique
8.4.2.20.South Korea Single cell multiomics market, by end user
8.4.2.21.Rest of Asia-Pacific Single cell multiomics market, by type
8.4.2.22.Rest of Asia-Pacific Single cell multiomics market, by application
8.4.2.23.Rest of Asia-Pacific Single cell multiomics market, by technique
8.4.2.24.Rest of Asia-Pacific Single cell multiomics market, by end user

8.4.3.Asia-Pacific market size and forecast, by type
8.4.4.Asia-Pacific market size and forecast, by application
8.4.5.Asia-Pacific market size and forecast, by technique

8.4.5.1.Asia-Pacific single-cell isolation and dispensing, by application
8.4.5.2.Asia-Pacific single-cell analysis, by application

8.4.6.Asia-Pacific market size and forecast, by end user

8.5.LAMEA

8.5.1.Key market trends, growth factors, and opportunities
8.5.2.Market size and forecast, by country

8.5.2.1.Brazil Single cell multiomics market, by type
8.5.2.2.Brazil Single cell multiomics market, by application
8.5.2.3.Brazil Single cell multiomics market, by technique
8.5.2.4.Brazil Single cell multiomics market, by end user
8.5.2.5.Saudi Arabia Single cell multiomics market, by type
8.5.2.6.Saudi Arabia Single cell multiomics market, by application
8.5.2.7.Saudi Arabia Single cell multiomics market, by technique
8.5.2.8.Saudi Arabia Single cell multiomics market, by end user
8.5.2.9.Rest of LAMEA Single cell multiomics market, by type
8.5.2.10.Rest of LAMEA Single cell multiomics market, by application
8.5.2.11.Rest of LAMEA Single cell multiomics market, by technique
8.5.2.12.Rest of LAMEA Single cell multiomics market, by end user

8.5.3.LAMEA market size and forecast, by type
8.5.4.LAMEA market size and forecast, by application
8.5.5.LAMEA market size and forecast, by technique

8.5.5.1.LAMEA single-cell isolation and dispensing, by application
8.5.5.2.LAMEA single-cell analysis, by application

8.5.6.LAMEA market size and forecast, by end user

CHAPTER 9:COMPANY PROFILES

9.1.BGI Genomics Co. Ltd.

9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.1.5.Business performance
9.1.6.Key strategic moves and developments

9.2.Bio-Rad Laboratories, Inc.

9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio
9.2.5.Business performance
9.2.6.Key strategic moves and developments

9.3.Danaher Corporation (Cytiva Life sciences)

9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio
9.3.5.Business performance
9.3.6.Key strategic moves and developments

9.4.Fluidigm Corporation

9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product portfolio
9.4.5.Business performance
9.4.6.Key strategic moves and developments

9.5.Illimina Inc.

9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Operating business segments
9.5.4.Product portfolio
9.5.5.Business performance

9.6.Mission Bio, Inc.

9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Product portfolio
9.6.5.Key strategic moves and developments

9.7.NanoString Technologies, Inc

9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.7.4.Product portfolio
9.7.5.Business performance
9.7.6.Key strategic moves and developments

9.8.Qiagen N.V.

9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Product portfolio
9.8.5.Business performance
9.8.6.Key strategic moves and developments

9.9.Takara Holdings Inc. (Takara Bio Group)

9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Operating business segments
9.9.4.Product portfolio
9.9.5.Business performance
9.9.6.Key strategic moves and developments

9.10.10x Genomics, Inc.

9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product portfolio
9.10.5.Business performance
9.10.6.Key strategic moves and developments

LIST OF TABLES

TABLE 01.GLOBAL SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 02.SINGLE CELL GENOMICS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 03.SINGLE CELL PROTEOMICS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 04.SINGLE CELL TRANSCRIPTOMICSMARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 05.SINGLE CELL METABOLOMICS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 06.GLOBAL SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 07.ONCOLOGY MARKET, BY REGION, 2020-2030($MILLION)
TABLE 08.CELL BIOLOGY MARKET, BY REGION, 2020-2030($MILLION)
TABLE 09.NEUROLOGY MARKET, BY REGION, 2020-2030($MILLION)
TABLE 10.OTHERS MARKET, BY REGION, 2020-2030($MILLION)
TABLE 11.GLOBAL SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030($MILLION)
TABLE 12.SINGLE-CELL ISOLATION AND DISPENSING MARKET, BY REGION, 2020-2030($MILLION)
TABLE 13.SINGLE-CELL ISOLATION AND DISPENSING, BY APPICATION, 2020–2030 ($MILLION)
TABLE 14.SINGLE-CELL ANALYSIS MARKET, BY REGION, 2020-2030($MILLION)
TABLE 15.SINGLE-CELL ANALYSIS, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 16.GLOBAL SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 17.ACADEMIC INSTITUTES MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 18.CONTRACT RESEARCH ORGANIZATIONS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 19.PHARMACEUTICAL AND BIOTECH COMPANIES MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 20.GLOBAL SINGLE CELL MULTIOMICS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 21.NORTH AMERICA SINGLE CELL MULTIOMICS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 22.U.S. SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 23.U.S. SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 24.U.S SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 25.U.S. SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 26.CANADA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 27.CANADA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 28.CANADA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 29.CANADA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 30.MEXICO SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 31.MEXICO SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 32.MEXICO SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 33.MEXICO SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 34.NORTH AMERICA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 35.NORTH AMERICA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 36.NORTH AMERICA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 37.NORTH AMERICA SINGLE-CELL ISOLATION AND DISPENSING, BY APPLICATION, 2020-2030
TABLE 38.NORTH AMERICA SINGLE-CELL ANALYSIS, BY APPLICATION, 2020-2030
TABLE 39.NORTH AMERICA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 40.EUROPE SINGLE CELL MULTIOMICS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 41.GERMANY SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 42.GERMANY SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 43.GERMANY SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 44.GERMANY SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 45.FRANCE SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 46.FRANCE SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 47.LAMEA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 48.FRANCE SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 49.UK SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 50.UK SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 51.UK SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 52.UK SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 53.ITALY SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 54.ITALY SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 55.ITALY SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 56.ITALY SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 57.SPAIN SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 58.SPAIN SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 59.LAMEA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 60.SPAIN SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 61.REST OF EUROPE SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 62.REST OF EUROPE SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 63.REST OF EUROPE SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 64.REST OF EUROPE SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 65.EUROPE SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 66.EUROPE SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 67.EUROPE SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 68.EUROPE SINGLE-CELL ISOLATION AND DISPENSING, BY APPLICATION, 2020-2030
TABLE 69.EUROPE SINGLE-CELL ANALYSIS, BY APPLICATION, 2020-2030
TABLE 70.EUROPE SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 71.ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 72.JAPAN SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 73.JAPAN SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 74.LAMEA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 75.JAPAN SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 76.CHINA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 77.CHINA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 78.LAMEA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 79.CHINA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 80.AUSTRALIA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 81.AUSTRALIA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 82.AUSTRALIA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 83.AUSTRALIA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 84.INDIA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 85.INDIA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 86.INDIA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 87.INDIA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 88.SOUTH KOREA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 89.SOUTH KOREA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 90.SOUTH KOREA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 91.SOUTH KOREA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 92.REST OF ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 93.REST OF ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 94.REST OF ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 95.REST OF ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 96.ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 97.ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 98.ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 99.ASIA-PACIFIC SINGLE-CELL ISOLATION AND DISPENSING, BY APPLICATION, 2020-2030
TABLE 100.ASIA-PACIFIC SINGLE-CELL ANALYSIS, BY APPLICATION, 2020-2030
TABLE 101.ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 102.LAMEA SINGLE CELL MULTIOMICS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 103.BRAZIL SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 104.BRAZIL SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 105.BRAZIL SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 106.BRAZIL SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 107.SAUDI ARABIA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 108.SAUDI ARABIA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 109.SAUDI ARABIA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 110.SAUDI ARABIA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 111.REST OF LAMEA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 112.REST OF LAMEA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 113.LAMEA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 114.REST OF LAMEA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 115.LAMEA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 116.LAMEA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 117.LAMEA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 118.LAMEA SINGLE-CELL ISOLATION AND DISPENSING, BY APPLICATION, 2020-2030
TABLE 119.LAMEA SINGLE-CELL ANALYSIS, BY APPLICATION, 2020-2030
TABLE 120.LAMEA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 121.BGI GENOMICS: COMPANY SNAPSHOT
TABLE 122.BGI GENOMICS: PRODUCT PORTFOLIO
TABLE 123.BGI GENOMICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 124.BIO-RAD: COMPANY SNAPSHOT
TABLE 125.BIO-RAD: OPERATING SEGMENTS
TABLE 126.BIO-RAD: PRODUCT PORTFOLIO
TABLE 127.BIO-RAD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 128.DANAHER: COMPANY SNAPSHOT
TABLE 129.DANAHER: OERATING SEGMENT
TABLE 130.DANAHER: PRODUCT PORTFOLIO
TABLE 131.DANAHER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 132.FLUIDIGM: COMPANY SNAPSHOT
TABLE 133.FLUIDIGM: OPERATING SEGMENTS
TABLE 134.FLUIDIGM: PRODUCT PORTFOLIO
TABLE 135.FLUIDIGM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 136.ILLUMINA: COMPANY SNAPSHOT
TABLE 137.ILLUMINA: OERATING SEGMENT
TABLE 138.ILLUMINA: PRODUCT PORTFOLIO
TABLE 139.MISSION BIO: COMPANY SNAPSHOT
TABLE 140.MISSION BIO: OPERATING SEGMENTS
TABLE 141.MISSION BIO: PRODUCT PORTFOLIO
TABLE 142.MISSION BIO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 143.NANOSTRING TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 144.NANOSTRING TECHNOLOGIES: OPERATING SEGMENTS
TABLE 145.NANOSTRING TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 146.NANOSTRING TECHNOLOGIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 147.QIAGEN: COMPANY SNAPSHOT
TABLE 148.QIAGEN: OERATING SEGMENT
TABLE 149.QIAGEN: PRODUCT PORTFOLIO
TABLE 150.QIAGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 151.TAKARA HOLDINGS: COMPANY SNAPSHOT
TABLE 152.TAKARA HOLDINGS: PRODUCT PORTFOLIO
TABLE 153.TAKARA HOLDINGS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 154.10X GENOMICS: COMPANY SNAPSHOT
TABLE 155.10X GENOMICS: OERATING SEGMENT
TABLE 156.10X GENOMICS.: PRODUCT PORTFOLIO
TABLE 157.10X GENOMICS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 01.GLOBAL SINGLE CELL MULTIOMICS MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018–2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021 (%)
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018–2021
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.MODERATE THREAT OF SUBSTITUTES
FIGURE 09.HIGH THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.COMPARATIVE ANALYSIS OF SINGLE CELL PROTEOMICSMARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 14.COMPARATIVE ANALYSIS OF BANDAGE SINGLE CELL PROTEOMICS MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 15.COMPARATIVE ANALYSIS OF SINGLE CELL TRANSCRIPTOMICS MARKET, BY COUNTRY,  2020 & 2030 ($MILLION)
FIGURE 16.COMPARATIVE ANALYSIS OF SINGLE CELL METABOLOMICS MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF ONCOLOGY MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF CELL BIOLOGY MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF NEUROLOGY MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF OTHERS MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 21.COMPARATIVE ANALYSIS OF SINGLE-CELL ISOLATION AND DISPENSING MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 22.ONCOLOGY MARKET, 2020–2030 ($MILLION)
FIGURE 23.CELL BIOLOGY MARKET, 2020–2030 ($MILLION)
FIGURE 24.NEUROLOGY MARKET, 2020–2030 ($MILLION)
FIGURE 25.OTHERS MARKET, 2020–2030 ($MILLION)
FIGURE 26.COMPARATIVE ANALYSIS OF SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 27.ONCOLOGY MARKET, 2020–2030 ($MILLION)
FIGURE 28.CELL BIOLOGY MARKET, 2020–2030 ($MILLION)
FIGURE 29.NEUROLOGY MARKET, 2020–2030 ($MILLION)
FIGURE 30.OTHERS MARKET, 2020–2030 ($MILLION)
FIGURE 31.COMPARATIVE ANALYSIS OF HOSPITAL AND CLINIC SINGLE CELL MULTIOMICS MARKET,  BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 32.COMPARATIVE ANALYSIS OF CONTRACT RESEARCH ORGANIZATIONS MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 33.COMPARATIVE ANALYSIS OF PHARMACEUTICAL AND BIOTECH COMPANIES MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 34.BGI GENOMICS: NET SALES, 2018–2020 ($MILLION)
FIGURE 35.BIO-RAD: NET SALES, 2018–2020 ($MILLION)
FIGURE 36.BIO-RAD: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 37.BIO-RAD: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 38.DANAHER: NET SALES, 2018–2020 ($MILLION)
FIGURE 39.DANAHER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 40.DANAHER: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 41.FLUIDIGM: NET SALES, 2018–2020 ($MILLION)
FIGURE 42.FLUIDIGM: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 43.ILLUMINA: NET SALES, 2018–2020 ($MILLION)
FIGURE 44.ILLUMINA: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 45.NANOSTRING TECHNOLOGIES: NET SALES, 2018–2020 ($MILLION)
FIGURE 46.10X GENOMICS: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 47.QIAGEN: NET SALES, 2018–2020 ($MILLION)
FIGURE 48.QIAGEN: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 49.TAKARA HOLDINGS: NET SALES, 2018–2020 ($MILLION)
FIGURE 50.TAKARA HOLDINGS: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 51.10X GENOMICS: NET SALES, 2018–2020 ($MILLION)
FIGURE 52.10X GENOMICS: REVENUE SHARE BY REGION, 2020 (%)

 
 

New advancements of single-cell technologies provide the opportunity to separate biological insights within individual cells. Single-cell sequencing technology is divided into genotypic and phenotypic, which help to determine the mechanisms to govern diseases and health. Furthermore, applications of single cell multiomics primarily include oncology, cell biology, neurology, stem cell, and immunology.

Furthermore, rise in technological advancements in single-cell analysis products and increase in number of large-scale genomics studies leveraging single-cell RNA Sequencing (sc-RNA) are expected to drive the market growth. Furthermore, increasing adoption of personalized medicine for screening and diagnostics of genetic disorders and rising disposable income in emerging economies drive the growth of the single cell multiomics market.

Moreover, North America is projected to account for a major share of the global single cell multiomics market during the forecast period. The market in the region is anticipated grow in the near future, owing to availability of developed healthcare infrastructure and continuous research activities for the development of advanced technologies. North America is expected to be followed by Europe during the forecast period.

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285,
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The total market value of Single Cell Multiomics market is $2,458.80 million in 2020.

A. The forcast period for Single Cell Multiomics market is 2021 to 2030

A. The market value of Single Cell Multiomics market in 2021 is $2,901.40 million.

A. The base year is 2020 in Single Cell Multiomics market

A. Top companies such as Bio-Rad Laboratories (Celsee, Inc.,), BGI Genomics Co. Ltd., Cytiva life science (Previously GE), Fluidigm Corporation, Illumina, Inc., 10x Genomics, NanoString Technologies, MissionBio, QIAGEN N.V. and Takara Bio held a high market position in 2020.

A. Oncology segment is the most influencing segment owing to increasing prevalence of cancer cases.

A. Increase in prevalence of technological advancements in single-cell analysis products, rise in number of large-scale genomics studies leveraging single-cell RNA Sequencing (sc-RNA) drives the growth of the single cell multiomics technology market. Moreover, increasing adoption of personalized medicine for the screening and diagnostics of genetic disorders and increasing disposable income in emerging economies drive the growth of the single cell multiomics market.

A. North America is projected to account for a major share of the global single cell multiomics market during the forecast period. The market in the region is anticipated grow in the near future, owing to availability of developed health care infrastructure and continuous research activities for the development of advanced technologies in the region. North America is expected to be followed by Europe during the forecast period.

A. Single Cell Multiomics products that are dry and used as primary or secondary dressings to protect the wound from infection

A. The single cell multiomics technology refers to numerous types of molecules from the individual cells, which is studied to understand the more biological insight than deducing from analyzing each molecular layer from separate cells.

Allied Market Research Allied Market Research Allied Market Research

RELATED TAGS

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Single Cell Multi-Omics Market

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers